Safety & tolerability 2010

Maitake and warfarin: a documented INR increase with combined use

A case report from Annals of Pharmacotherapy: a patient on a stable warfarin dose developed a rise in INR (a coagulation measure) after adding maitake extract. After the extract was stopped, INR returned to target. A single documented signal — but a clinically important one: anyone on anticoagulants should monitor INR when taking maitake.

Hanselin M.R., Vande Griend J.P., Linnebur S.A. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother. 2010;44(1):223–224.

Rationale

Warfarin dosing is narrow-windowed — INR drift means bleeding or clotting risk. Interactions with supplements are frequently underreported; this case documented one for maitake.

Methods

A case report with serial INR measurements: a patient stable on warfarin added a maitake extract; INR rose. On discontinuing the extract, INR returned to the target range — a dechallenge-consistent pattern.

Results

INR elevation coincided with maitake intake and normalized after withdrawal — the classic single-patient causality signal (positive dechallenge).

Conclusions

A documented interaction signal: maitake can potentiate warfarin. One case is the weakest evidence tier, but for INR-destabilization it is exactly the kind of signal that matters clinically.

Worth noting

The mechanism is plausible via polysaccharide/fiber effects on vitamin K handling or direct anticoagulant activity, but unproven. For readers on warfarin or similar anticoagulants: maitake extract is not a neutral food at this dose — INR monitoring applies.

Sources

  1. MSKCC About Herbs: Maitake — Herb-Drug Interactions section
  2. Ann Pharmacother 2010;44(1):223-4 — Hanselin, Vande Griend, Linnebur